2025 LBDA New Investigator Pilot Study Award
The Lewy Body Dementia Association (LBDA) New Investigator Pilot Study Award is intended to support pilot translational or clinical studies for the purpose of developing preliminary data to be used in future grant applications. The program is open both to early-stage investigators, and to more established researchers from other fields, who have not yet received an NIH R01 in Lewy body dementia (LBD) research.
The aim of the program in 2025 is to drive progress in clinical trials of disease-modifying therapies for people with LBD. Example topics that are in scope include utilization of biomarkers for sample enrichment/stratification or to monitor disease progression, characterization of early disease states that may offer opportunities for intervention, outcome measures, and other topics that enable advancements in trials for disease-modifying therapies.
Under this request for applications, LBDA intends to fund three awards.
Full details are available on the Request for Applications, which is available through ProposalCentral. Potential applicants are encouraged to view the opportunity within ProposalCentral well in advance of the LOI deadline.
2025 LBDA Research Funding Awards
Mentorship Program Award
This program aims to promote the continued development of newly trained researchers, or experienced researchers new to Lewy body dementia (LBD), into world-class LBD investigators.
RCOE New Site Award
The LBDA Research Centers of Excellence (RCOE) program aims to increase access to clinical care expertise and establish a clinical trials-ready network of nationally recognized LBD research centers.
LBDA Research Project Award
This award supports research in areas identified by LBDA as strategic research priorities that address the unmet needs of people with LBD and their care partners.